Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Aug 6;9(9):e95. doi: 10.1016/S2213-2600(21)00362-3

Correction to Lancet Respir Med 2021; published online June 11. https://doi.org/10.1016/S2213-2600(21)00214-9

PMCID: PMC8346237  PMID: 34370975

The content is available as a PDF (106.9 KB).

Acknowledgments

Bauer A, Schreinlechner M, Sappler N, et al. Discontinuation versus continuation of renin-angiotensin system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med 2021; published online June 11. https://doi.org/10.1016/S2213-2600(21)00214-9—For this Article, Johannes Siebermair's name was incorrectly spelled in the ACEI-COVID investigators indexing table; the Appendix has also been corrected. These corrections have been made to the online version as of July 30, 2021.


Articles from The Lancet. Respiratory Medicine are provided here courtesy of Elsevier

RESOURCES